This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Single cell variant to enhancer to gene map for coronary artery disease.
medRxiv : the preprint server for health sciences · 2024
Latest funding
- $1,017,450
Unravelling the role of a novel gene SVIL in hypertrophic cardiomyopathy
CIHR · 2026 · Nominated PI
1 publications.
Single cell variant to enhancer to gene map for coronary artery disease.
Amrute JM, Lee PC, Eres I, Lee CJM, Bredemeyer A, Sheth MU, Yamawaki T, Gurung R, Anene-Nzelu C, Qiu WL, Kundu S, Li DY, Ramste M, Lu D, Tan A, Kang CJ, Wagoner RE, Alisio A, Cheng P, Zhao Q, Miller CL, Hall IM, Gupta RM, Hsu YH, Haldar SM, Lavine KJ, Jackson S, Andersson R, Engreitz JM, Foo RS, Li CM, Ason B, Quertermous T, Stitziel NO
Unravelling the role of a novel gene SVIL in hypertrophic cardiomyopathy
Principal investigators: Anene-Nzelu, Chukwuemeka G
Keywords: Cardiovascular; Hypertrophic Cardiomyopathy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.